Paragraph 3 Fees

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

Sch 2, paras 2, 3 am by Medicines (Products for Animal Use—Fees) 2001 regs 2(1), 3, Schedule, Pt I
regs.12 14, Sch.1, Pts.l-V, Sch.2 amended by Medicines (Products for Animal Use—Fees) 1999 reg.2, Sch.
regs 12,13.14. Sch 1. Pt.II, paras.1 -3,6-9, Pt.III. paras 4,5, Pt.IV, paras.1- 3,5-7, Pt.V, paras.1 -3. Sch.2. paras.2.3 amended by Medicines (Products for Animal Use—Fees) 2000 reg.2. Sch.
Sch 2, paras 2, 3 am by Medicines (Products for Animal Use—Fees) 2003 regs 3(1), (7), 4, Sch 4
Sch 2, para 2, Tables A–C am by Medicines (Products for Animal Use—Fees) 2003 regs 3(1), (7), 4, Sch 4
Sch 2, paras 2, 3 am by Medicines (Products for Animal Use—Fees) 2002 regs 2(1), 3, Schedule

(1)

The fee payable for any inspection of either or both of the premises and the procedures for the quality control of a biological product, in respect of which a marketing authorisation or product licence has been granted or applied for, is £1,210 for each such product which is not a dormant biological product.

(2)

A fee of £55 is payable for any such inspection in connection with such an authorised or licensed biological product (not being a dormant biological product) for which a marketing authorisation or product licence was granted because it was identical to an existing product.